Revolution Medicines, Inc. (RVMD) Revenue History
Annual and quarterly revenue from 2017 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
Revenue Breakdown (FY 2022)
RVMD's revenue distribution by segment and geography for fiscal year 2022
By Product/Segment
RVMD Revenue Analysis (2017–2025)
As of March 2, 2026, Revolution Medicines, Inc. (RVMD) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2025) recorded $0 in revenue.
Looking at the longer-term picture, RVMD's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $50.0 million in 2019.
Revenue diversification analysis shows RVMD's business is primarily driven by Collaboration Revenue Member (100%). With over half of revenue concentrated in Collaboration Revenue Member, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including INCY (+21.2% YoY), GMAB (+21.0% YoY), and EXEL (+9.9% YoY). Compare RVMD vs INCY →
Peer Comparison
Compare RVMD's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| RVMDCurrent | $0 | - | - | - | |
| INCY | $5.1B | +21.2% | +14.0% | 26.1% | |
| GMAB | $21.5B | +21.0% | +32.0% | 31.1% | |
| EXEL | $2.3B | +9.9% | +18.6% | 37.6% | |
| IBRX | $15M | +1026.0% | +221.4% | -2334.2% | |
| MRUS | $35M | +55.9% | +4.7% | -753.0% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $-16,558,000 | - | $-1,182,369,000 | - |
| 2024 | $0 | -100.0% | $0 | - | $-689,524,000 | - |
| 2023 | $11.6M | -67.3% | $11.6M | 100.0% | $-487,185,000 | -4207.1% |
| 2022 | $35.4M | +20.4% | $35.4M | 100.0% | $-258,279,000 | -730.0% |
| 2021 | $29.4M | -31.6% | $29.4M | 100.0% | $-188,008,000 | -639.7% |
| 2020 | $43.0M | -14.1% | $43.0M | 100.0% | $-110,697,000 | -257.5% |
| 2019 | $50.0M | +148.2% | $50.0M | 100.0% | $-54,120,000 | -108.2% |
| 2018 | $20.2M | - | $20.2M | 100.0% | $-40,329,000 | -200.0% |
| 2017 | $0 | - | $-26,586,000 | - | $-31,129,000 | - |
See RVMD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RVMD Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare RVMD vs AGIO
See how RVMD stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is RVMD's revenue growth accelerating or slowing?
RVMD TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is RVMD's long-term revenue growth rate?
Revolution Medicines, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is RVMD's revenue distributed by segment?
RVMD reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2017-2025 are available for download. Segment mix reveals concentration and diversification trends.